<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04682418</url>
  </required_header>
  <id_info>
    <org_study_id>DHF-VAP-002</org_study_id>
    <nct_id>NCT04682418</nct_id>
  </id_info>
  <brief_title>Pedicle Screw Placement With XVS</brief_title>
  <official_title>Feasibility Study of Pedicle Screw Placement in the Spine With the XVISION SPINE System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Augmedics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Augmedics</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Open label, prospective, single arm, multi-center study. Pedicle screws placement in&#xD;
      sacral/lumbar vertebrae will be performed via open procedural technique, by at least two (2)&#xD;
      different surgeons, using the XVISION SPINE system.&#xD;
&#xD;
      Pedicle screw placement accuracy will be assessed by two independent, experienced&#xD;
      radiologists, using the Gertzbein score.&#xD;
&#xD;
      Subjects will undergo intraoperative 3D scan prior to screws placement to enable 3D model&#xD;
      rendering and XVISION SPINE system registration.&#xD;
&#xD;
      Subjects will undergo intraoperative 3D scan post procedure to enable offline scoring of&#xD;
      pedicle screw placement using the Gertzbein score.&#xD;
&#xD;
      Surgeons performing the procedures will be requested to fill in usability questionnaires at&#xD;
      the end of the procedure&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 20, 2018</start_date>
  <completion_date type="Actual">July 7, 2021</completion_date>
  <primary_completion_date type="Actual">March 16, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>accurate placement of pedicle screws</measure>
    <time_frame>through study completion , an average of 6 months.</time_frame>
    <description>accurate placement will be evaluated using Gertzbein and Robbins</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>usability and ease of use of the system: questionnaire</measure>
    <time_frame>The surgeon fills a questionnaire after the surgery, within 7 days.</time_frame>
    <description>usability will be evaluated by questionnaire</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Spine Fusion</condition>
  <arm_group>
    <arm_group_label>xvision Spine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>xvision Spine sytem</intervention_name>
    <description>pedicle screw placement will be performed using the XVS navigation system</description>
    <arm_group_label>xvision Spine</arm_group_label>
    <other_name>XVS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Subjects aged 18 - 80 yrs.&#xD;
&#xD;
          2. Subjects with Spondylosis scheduled to undergo an elective short (6 or less&#xD;
             consecutive vertebrae) S1-L1 open spinal fixation surgery using pedicle screws.&#xD;
&#xD;
          3. Subjects requiring a posterior approach surgical procedure.&#xD;
&#xD;
          4. Subjects with normal global spinal alignment (coronal, sagittal view) and/ or patients&#xD;
             with degenerative spine disorders.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Subjects with severe Osteoporosis (T score &lt;-3.5)&#xD;
&#xD;
          2. Subjects with kyphosis at the operated area (â‰¥ stage 3)&#xD;
&#xD;
          3. Subjects with Spondylolisthesis Grade III and above.&#xD;
&#xD;
          4. Subjects scheduled for revision fusion surgery (prior laminectomy or discectomy is not&#xD;
             excluded).&#xD;
&#xD;
          5. Subjects with significant abnormalities of bones (e.g. osteogenesis imperfecta,&#xD;
             tumors, infection or malignancy, etc.)&#xD;
&#xD;
          6. Subjects with neurologic diseases or damage (e.g. due to trauma, tumor, Charcot-Marie&#xD;
             Tooth, Guillain-Barre syndrome, cerebral palsy, spina bifida or neurofibroma)&#xD;
&#xD;
          7. Subjects with spinal cord abnormalities with any neurologic symptoms or signs&#xD;
&#xD;
          8. Paraplegia.&#xD;
&#xD;
          9. Pedicle fracture documented before or during surgery.&#xD;
&#xD;
         10. Women pregnant or lactating&#xD;
&#xD;
         11. Subjects requiring anterior release or instrumentation.&#xD;
&#xD;
         12. Subjects who are unwilling to sign written informed consent and assent to participate&#xD;
             in the study.&#xD;
&#xD;
             -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Haemek MC</name>
      <address>
        <city>Afula</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sheeba Medical Center</name>
      <address>
        <city>Tel HaShomer</city>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asaf Harofeh</name>
      <address>
        <city>Tzrifin</city>
        <zip>70300</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>April 5, 2019</study_first_submitted>
  <study_first_submitted_qc>December 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 23, 2020</study_first_posted>
  <last_update_submitted>August 22, 2021</last_update_submitted>
  <last_update_submitted_qc>August 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

